Valence-Logo
Beliebt
Anmelden

Zur Watchlist hinzufügen

Regentis Biomaterials Ltd...

NYSE American: RGNT · Echtzeitkurs · USD
2.10
+0.04 (1.94%)
Zum Schluss: Aug 21, 2026, 3:59 PM
2.15
+2.38%
Nachbörslich: 7:49 PM

Kurs, die wichtigsten Kennzahlen und die neuesten Nachrichten an einem Ort.

Regentis Biomaterials Ltd. (RGNT) Aktienkurs, Analyse & Daten

1.94%
Geld2.15
Marktkapitalisierung14.75 Mio
Umsatz (TTM)n/a
Nettogewinn (TTM)-13.69 Mio
n/a
-24.16
n/a
n/a
KBV (TTM)2.29
KUV (TTM)n/a
Termin Quartalszahlenn/a
Brief2.17
Volumen37,127
Ø Vol. (20D)5,409,803
Eröffnung2.05
Vortagesschluss2.06
Tagesspanne2.07 - 2.17
52-Wk Range1.23 - 15.50
Analystn/a
Kursziel10 (376.19%)
Dividendenn/a
Ex-Dividenden-Datumn/a

Über RGNT

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the ...

[Mehr lesen]
Branche Medical Instruments & Supplies
Sektor Healthcare
IPO Datum Dec 4, 2025
Mitarbeiter n/a
Börse NYSE American
Tickersymbol RGNT
Website https://www.regentis.co.il
Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Regentis Biomaterials 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -13.65 Mio, ein Rückgang von -384.27 %.

Finanzberichte

Analystenprognose

Laut 1 Analysten-Bewertungen ist die durchschnittliche Einschätzung für die RGNT-Aktie "null". Das 12-Monats-Kursziel liegt bei 10, was Aufwärtspotenzial von 376.19% gegenüber dem aktuellen Kurs entspricht.

Aktienprognosen
news image

vor 2 Monaten · Barchart

This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation

EPR Properties offers income investors a rare combination: a 6.3% monthly dividend yield, a conservative 73% payout ratio, and diversified exposure to experiential real estate well beyond movie theatr...

news image

vor 2 Monaten · Stocktwits

Why Did RGNT Stock Surge More Than 850% Today?

Regentis Biomaterials filed a notice to withdraw its Form F-1 registration statement, indicating that it did not wish to proceed with a proposed public offering announced last month.

news image

vor 5 Monaten · Insider Monkey

Regentis Biomaterials (RGNT) Appoints New CFO/CBO as GelrinC Nears Commercial Launch

Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) is one of the best up and coming penny stocks to buy. On February 4, Regentis Biomaterials appointed Ori Gon as Chief Financial Officer and Chief Busines...

news image

vor 8 Monaten · MT Newswires

Sector Update: Health Care Stocks Slide Late Afternoon

Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the Health

news image

vor 8 Monaten · MT Newswires

Sector Update: Health Care Stocks Softer in Afternoon Trading

Health care stocks declined Thursday afternoon with the NYSE Health Care Index dropping 0.5% and the